AAAAAA

   
Results: 1-18 |
Results: 18
Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, andtopotecan with peripheral-blood stem-cell support as front-line therapy
Authors: Schilder, RJ Gallo, JM Millenson, MM Bookman, MA Weiner, LM Rogatko, A Rogers, B Padavic-Shallers, K Boente, M Rosenblum, N Adams, AL Ciccotto, S Ozols, RF
Citation: Rj. Schilder et al., Phase I trial of multiple cycles of high-dose carboplatin, paclitaxel, andtopotecan with peripheral-blood stem-cell support as front-line therapy, J CL ONCOL, 19(4), 2001, pp. 1183-1194
Kennedy's disease: A triplet repeat disorder or a motor neuron disease?
Authors: Gallo, JM
Citation: Jm. Gallo, Kennedy's disease: A triplet repeat disorder or a motor neuron disease?, BRAIN RES B, 56(3-4), 2001, pp. 209-214
Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model
Authors: Guo, PG Ma, JG Li, SL Guo, ZW Adams, AL Gallo, JM
Citation: Pg. Guo et al., Targeted delivery of a peripheral benzodiazepine receptor ligand-gemcitabine conjugate to brain tumors in a xenograft model, CANC CHEMOT, 48(2), 2001, pp. 169-176
Androgen-induced up-regulation of tubulin isoforms in neuroblastoma cells
Authors: Butler, R Leigh, PN Gallo, JM
Citation: R. Butler et al., Androgen-induced up-regulation of tubulin isoforms in neuroblastoma cells, J NEUROCHEM, 78(4), 2001, pp. 854-861
Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3 beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes
Authors: Connell, JW Gibb, GM Betts, JC Blackstock, WP Gallo, JM Lovestone, S Hutton, M Anderton, BH
Citation: Jw. Connell et al., Effects of FTDP-17 mutations on the in vitro phosphorylation of tau by glycogen synthase kinase 3 beta identified by mass spectrometry demonstrate certain mutations exert long-range conformational changes, FEBS LETTER, 493(1), 2001, pp. 40-44
Pharmacodynamic-mediated reduction of temozolomide tumor concentrations bythe angiogenesis inhibitor TNP-470
Authors: Ma, JG Pulfer, S Li, SL Chu, JX Reed, K Gallo, JM
Citation: Jg. Ma et al., Pharmacodynamic-mediated reduction of temozolomide tumor concentrations bythe angiogenesis inhibitor TNP-470, CANCER RES, 61(14), 2001, pp. 5491-5498
Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patientswith refractory solid malignancies
Authors: Hudes, GR Szarka, CE Adams, A Ranganathan, S McCauley, RA Weiner, LM Langer, CJ Litwin, S Yeslow, G Halberr, T Qian, MX Gallo, JM
Citation: Gr. Hudes et al., Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patientswith refractory solid malignancies, CLIN CANC R, 6(8), 2000, pp. 3071-3080
Phramacokinetics of the chemopreventive agent oltipraz and of its metabolite M3 in human subjects after a single oral dose
Authors: O'Dwyer, PJ Szarka, C Brennan, JM Laub, PB Gallo, JM
Citation: Pj. O'Dwyer et al., Phramacokinetics of the chemopreventive agent oltipraz and of its metabolite M3 in human subjects after a single oral dose, CLIN CANC R, 6(12), 2000, pp. 4692-4696
Population pharmacokinetic model for topotecan derived from phase I clinical trials
Authors: Gallo, JM Laub, PB Rowinsky, EK Grochow, LB Baker, SD
Citation: Jm. Gallo et al., Population pharmacokinetic model for topotecan derived from phase I clinical trials, J CL ONCOL, 18(12), 2000, pp. 2459-2467
Application of microdialysis to characterize drug disposition in tumors
Authors: Chu, JX Gallo, JM
Citation: Jx. Chu et Jm. Gallo, Application of microdialysis to characterize drug disposition in tumors, ADV DRUG DE, 45(2-3), 2000, pp. 243-253
Mutually exclusive expression of beta(III)-tubulin and vimentin in adrenalcortex carcinoma SW13 cells
Authors: Butler, R Robertson, J Gallo, JM
Citation: R. Butler et al., Mutually exclusive expression of beta(III)-tubulin and vimentin in adrenalcortex carcinoma SW13 cells, FEBS LETTER, 470(2), 2000, pp. 198-202
Pharmacokinetics: Model structure and transport systems
Authors: Gallo, JM
Citation: Jm. Gallo, Pharmacokinetics: Model structure and transport systems, DRUG PHARM, 102, 2000, pp. 55-86
Distribution of small magnetic particles in brain tumor-bearing rats
Authors: Pulfer, SK Ciccotto, SL Gallo, JM
Citation: Sk. Pulfer et al., Distribution of small magnetic particles in brain tumor-bearing rats, J NEURO-ONC, 41(2), 1999, pp. 99-105
Selective protection of 2 ',2 '-difluorodeoxycytidine (gemcitabine)
Authors: Guo, ZW Gallo, JM
Citation: Zw. Guo et Jm. Gallo, Selective protection of 2 ',2 '-difluorodeoxycytidine (gemcitabine), J ORG CHEM, 64(22), 1999, pp. 8319-8322
Activation of the AT(2) receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum
Authors: Cote, F Do, TH Laflamme, L Gallo, JM Gallo-Payet, N
Citation: F. Cote et al., Activation of the AT(2) receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum, J BIOL CHEM, 274(44), 1999, pp. 31686-31692
Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres
Authors: Pulfer, SK Gallo, JM
Citation: Sk. Pulfer et Jm. Gallo, Enhanced brain tumor selectivity of cationic magnetic polysaccharide microspheres, J DRUG TAR, 6(3), 1998, pp. 215-227
Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor
Authors: Ma, JG Fei, ZL Klein-Szanto, A Gallo, JM
Citation: Jg. Ma et al., Modulation of angiogenesis by human glioma xenograft models that differentially express vascular endothelial growth factor, CLIN EXP M, 16(6), 1998, pp. 559-568
Use of capillary electrophoresis methods to characterize the pharmacokinetics of antisense drugs
Authors: Chen, SH Gallo, JM
Citation: Sh. Chen et Jm. Gallo, Use of capillary electrophoresis methods to characterize the pharmacokinetics of antisense drugs, ELECTROPHOR, 19(16-17), 1998, pp. 2861-2869
Risultati: 1-18 |